GENAI CLOSES TRANSACTION AND WILL BEGIN TRADING ON THE CANADIAN SECURITIES EXCHANGE AT MARKET OPEN‎

Rhea-AI Summary

Generative AI Solutions Corp. (formerly Idle Lifestyle) has received approval from the Canadian Securities Exchange (CSE) to list its Common Shares under the symbol AICO, with trading commencing on April 19, 2023. This follows a business combination with Ultron Capital Corp, finalized on April 17, 2023, where GenAI acquired all securities of Ultron for 51,176,001 Common Shares. The company aims to lead in AI innovation, developing solutions across multiple sectors, including healthcare and finance. CEO Ryan Selby highlighted the potential of their AI solutions, such as 'Classmate,' which assists students in their studies. The board of directors was reconstituted following the transaction, with Selby as CEO and Paul Ciullo as CFO. Shareholder approvals were secured at meetings conducted on April 11, 2023, meeting regulatory conditions for the transaction.

Positive

• Approval received from the CSE for trading under symbol AICO.
• Successful business combination with Ultron Capital Corp, strengthening company position.
• Development of innovative AI solutions aimed at multiple industries, including healthcare and finance.

Negative

• None.

VANCOUVER, BC, April 18, 2023 /PRNewswire/ - Generative AI Solutions Corp. ("GenAI" or the "Company") (CSE: AICO) (‎FSE: 99L.F) (OTC: IDLSF) is pleased to announce that Generative AI Solutions Corp. (formerly Idle Lifestyle Inc. (CSE: IDLE)) has been granted approval by the Canadian Securities Exchange (the "CSE")  to begin trading of its Common Shares (the "Listing") under the symbol "AICO", and it is expected that trading will begin at the open of markets tomorrow, Wednesday, April 19, 2023. The Listing is the result of the closing of the Company's business combination with Ultron Capital Corp. ("Ultron") pursuant to the terms of the business combination agreement (the "Business Combination Agreement") dated February 16, 2023 (the "Transaction") previously announced in detail in the Company's February 16, 2023 news release. GenAI is committed to leading the artificial intelligence ("AI") revolution, transforming the way businesses operate, and driving growth and profitability for consumers and businesses.

Ryan Selby, CEO, comments "Our team of experts in data science, software engineering, and AI technology is continuously working to develop innovative AI solutions to meet the ever-changing needs of our clients. By leveraging the power of machine learning and deep learning algorithms, our AI solutions can quickly analyze vast amounts of data and provide businesses and consumers with valuable insights to make informed decisions. We have seen tremendous opportunities in providing AI solutions to healthcare, finance, manufacturing, and logistics industries, where we can optimize operations, reduce costs, and increase revenue. Our initial AI solution "Classmate" is geared towards helping students with their studies allowing them to gain increased knowledge in a particular field of study and save time searching for information. As we continue to invest in research and development, we are confident in our ability to remain at the forefront of AI innovation, and we are excited about the opportunities and growth potential that lies ahead for the Company".

The Transaction

As previously announced, the Company, Ultron and a wholly owned subsidiary of the Company entered into the Business Combination Agreement on February 16, 2023, under which GenAI acquired all of the issued and outstanding securities of Ultron in exchange for 51,176,001 Common Shares of the Company. The Transaction resulted in a reverse takeover of the Company by Ultron, which constituted a fundamental change of the Company, as defined in the policies of the CSE.

Pursuant to the terms of the Business Combination Agreement, completion of the Transaction was subject to: (i) approval from the CSE; (ii) approval of certain pre-closing matters from the shareholders of the Company at its annual and special meeting of shareholders held on April 11, 2023 (the "GenAI Meeting"), as more fully explained in the Company's Management Information Circular, dated March 10, 2023; and (iii) approval of the amalgamation of Ultron and 1399318 B.C. Ltd. (the "Amalgamation") from the shareholders of Ultron at its special meeting of shareholders held on April 11, 2023 (the "Ultron Meeting").

The Transaction closed in full on April 17, 2023.

As a result of the Transaction, the Company's board of directors has been reconstituted and is now comprised of the following individuals: Ryan Selby, Aaron Bowden and Patrick Gray. In addition, the Company's board has appointed Ryan Selby as the Chief Executive Officer and Paul Ciullo as Chief Financial Officer.

GenAI Meeting

At the GenAI Meeting, the following resolutions were passed, satisfying the aforementioned closing conditions to the Transaction:

1. An ordinary resolution of the shareholders of the Company fixing the number of directors at three for the ensuing year;
   
   
2. An ordinary resolution of the shareholders of the Company electing Ryan Selby, Aaron Bowden and Patrick Gray to the Company's board of directors until the close of the next annual meeting of shareholders or until their successors are elected or appointed;
   
   
3. An ordinary resolution re-appointing Manning Elliott LLP as the Company's auditor, with its remuneration to be set by the Company's board of directors; and
   
   
4. A special resolution of the holders of the Company's Subordinate Voting Shares and the Company's Multiple Voting Shares, each voting as a separate class, approving an alteration to the Company's Notice of Articles (the "Share Reclassification") to: (i) create a new class of Common Shares; (ii) alter the rights and restrictions of the Company's Multiple Voting Shares and Subordinate Voting Shares; and (iii) re-designate the Subordinate Voting Shares as "Class B Shares".

Following the GenAI Meeting, the Company gave effect to the Share Reclassification and, upon conversion of the Multiple Voting Shares to Subordinate Voting Shares, deleted the Multiple Voting Shares from the Company's share structure, and reclassified the Subordinate Voting Shares as Common Shares.

The Company obtained in writing resolutions signed by holders of the majority of the Common Shares to give effect to the Transaction in accordance with the policies of the CSE.

Ultron Meeting

At the Ultron Meeting, the shareholders of Ultron approved the Amalgamation by special resolution, thereby satisfying the aforementioned closing condition to the Transaction.

Additional Information

For further information, please refer to the Company's listing statement filed under the Company's profile on SEDAR.

On Behalf of the Board,‎

Ryan Selby
CEO, Director, and Chairman of the Board

Generative AI Solutions Corp.
Toll-free North America: +1-833-879-7632‎
Outside North America: +1-406-879-7632
info@genai-solutions.com 
www.genai-solutions.com

ABOUT GENERATIVE AI SOLUTIONS CORP.

GenAI is a pioneering artificial intelligence company focused on developing transformative AI-powered tools for businesses and consumers across multiple industries. At GenAI, our mission is to harness the power of artificial intelligence to create transformative tools that benefit businesses and consumers across various industries. Our team of talented AI professionals and engineers are dedicated to developing state-of-the-art AI-based solutions that have broad applicability and can be seamlessly integrated into diverse workflows. By leveraging our expertise in machine learning, natural language processing, and data analytics, we build versatile, high-performance tools that redefine efficiency, productivity, and user experience.

For more information, visit www.genai-solutions.com.

FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking information" which may include, but is not limited to, ‎information with respect to the activities, events or developments that the Company expects or anticipates ‎will or may occur in the future, such as: the listing of the Company's Common Shares on the CSE; the timing of the commencement of trading of the Common Shares;  the Company's ability to produce artificial intelligence tools and solutions; the ability of the Company to drive growth and profitability for consumers and businesses; and the opportunities for artificial intelligence in healthcare, finance, manufacturing, and logistics industries. Such forward-looking information is often, but not always, identified by the ‎use of words and phrases such as "plans," "expects," "is expected," "budget," "scheduled," "estimates," ‎‎"forecasts," "intends," "anticipates," or "believes" or variations (including negative variations) of such words ‎and phrases, or state that certain actions, events or results "may," "could," "would," "might" or "will" be ‎taken, occur or be achieved. Various assumptions or factors are typically applied in drawing conclusions or making ‎the forecasts or projections set out in forward-looking information. Those assumptions and factors are ‎based on information currently available to the Company.

Forward looking information involves known and unknown risks, uncertainties ‎and other risk factors which may cause the actual results, performance or achievements to be materially ‎different from any future results, performance or achievements expressed or implied by the forward-looking ‎information. Such risks include risks related to increased competition and current global financial conditions, access and supply risks, ‎reliance on key personnel, operational risks, regulatory risks, financing, risks related to the regulation and oversight of artificial intelligence, capitalization and liquidity risks. ‎Although the Company has attempted to identify important factors that could cause actual results to differ ‎materially from those contained in forward-looking information, there may be other factors that cause results ‎not to be as anticipated, estimated or intended. There can be no assurance that such information will prove ‎to be accurate, as actual results and future events could differ materially from those anticipated in such ‎statements. Accordingly, readers should not place undue reliance on forward-looking information. The ‎Company undertakes no obligation, except as otherwise required by law, to update these forward-looking ‎statements if management's beliefs, estimates or opinions, or other factors change.‎

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or ‎accuracy of the content of this news release.‎

View original content to download multimedia:https://www.prnewswire.com/news-releases/genai-closes-transaction-and-will-begin-trading-on-the-canadian-securities-exchange-at-market-open-301801066.html

SOURCE GENERATIVE AI SOLUTIONS CORP.

FAQ

When will Generative AI Solutions Corp. start trading under the symbol AICO?

Trading under the symbol AICO will commence on April 19, 2023.

What was the significant transaction recently completed by IDLSF?

Generative AI Solutions Corp. completed a business combination with Ultron Capital Corp, resulting in a reverse takeover.

What kind of AI solutions is Generative AI Solutions Corp. focused on?

The company is focused on developing AI solutions for various sectors, including healthcare, finance, and education.

Who are the current executives of Generative AI Solutions Corp.?

The current CEO is Ryan Selby, and the CFO is Paul Ciullo.

What impact does the business combination have on IDLSF's stock?

The business combination is expected to enhance the company's market position, potentially affecting its stock positively.